Indiana
CNS clinical trials in Indiana
34 CNS studies are recruiting participants at sites in 13 cities across Indiana as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Indiana city with a recruiting study
By research area: Depression (11), Migraine (7), Parkinson's Disease (7), Multiple Sclerosis (4), Schizophrenia (3), Epilepsy (2).
Indianapolis (20), Fort Wayne (3), Bloomington (2), Carmel (2), Evansville (2), Westfield (2), Avon (1), Goshen (1), Merrillville (1), New Albany (1), Newburgh (1), Richmond (1), West Lafayette (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Depression: recently updated in Indiana
Basic details from each study's public record (the 12 most recently updated of 34). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
E-Mindfulness Approaches for Living After Breast Cancer
- Phase 3
- Ages 18 to 50
- All sexes
- Sponsor
- NRG Oncology
- Recruiting in
- Goshen · New Albany · Richmond
- Registry record
- NCT06748222 · updated
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eli Lilly and Company
- Recruiting in
- Indianapolis
- Registry record
- NCT07412756 · updated
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
- Observational
- From 18 months, up to 11 years
- All sexes
- Sponsor
- State University of New York at Buffalo
- Recruiting in
- Bloomington
- Registry record
- NCT07048574 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Indiana on ClinicalTrials.gov.
Parkinson's disease: recently updated in Indiana
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Fort Wayne
- Registry record
- NCT06952504 · updated
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Fort Wayne · Indianapolis
- Registry record
- NCT06966700 · updated
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Indianapolis
- Registry record
- NCT06623422 · updated
A Study of Buntanetap in Participants With PD
- Phase 2/3
- Ages 40 to 85
- All sexes
- Sponsor
- Annovis Bio Inc.
- Recruiting in
- Indianapolis
- Registry record
- NCT07284784 · updated
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- Phase 2
- Ages 30 to 80
- All sexes
- Sponsor
- Appello Pharmaceuticals, Inc.
- Recruiting in
- Indianapolis
- Registry record
- NCT07432958 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Indiana on ClinicalTrials.gov.
Multiple sclerosis (MS): recently updated in Indiana
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- Phase 3
- Ages 18 to 60
- All sexes
- Sponsor
- Zenas BioPharma (USA), LLC
- Recruiting in
- Indianapolis
- Registry record
- NCT07299019 · updated
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- TG Therapeutics, Inc.
- Recruiting in
- Avon
- Registry record
- NCT06433752 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Indiana on ClinicalTrials.gov.
Epilepsy: recently updated in Indiana
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Rapport Therapeutics Inc.
- Recruiting in
- Fort Wayne
- Registry record
- NCT07563881 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Indiana on ClinicalTrials.gov.
Migraine: recently updated in Indiana
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Recruiting in
- Indianapolis · Merrillville
- Registry record
- NCT07816367 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Indiana on ClinicalTrials.gov.
Ask about studies in Indiana
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections